Jackson Hole Capital Partners, LLC Cassava Sciences Inc Transaction History

Jackson Hole Capital Partners, LLC

  • $454 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$36.77 - $90.91 $171,348 - $423,640
-4,660 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$41.79 - $135.3 $194,741 - $630,498
4,660 New
4,660 $289,000

Others Institutions Holding SAVA

# of Institutions
184
Shares Held
13.3M
Call Options Held
1.38M
Put Options Held
2.04M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.14B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Jackson Hole Capital Partners, LLC Portfolio

Follow Jackson Hole Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email